Tag: randomised controlled trial
ECR 2022: Interventional oncology is the fourth pillar of oncology—a shift...
With cancer cases growing worldwide and an increased number of late-stage diseases in elderly patients, there is an increasing need for an integrated approach....
Novel paclitaxel-nano-coated balloon achieves lower incidence of restenosis than plain balloon...
Two-year results of EffPac—a randomised controlled trial to assess the safety and efficacy of a novel drug-coated balloon (DCB) with a nanotechnology coating—have been...
Registries will help determine survival of IO as a specialty
The primary importance of collecting data from registries would be to establish outcome data to prove the value of the interventional oncologic therapies to healthcare...
ATTRACT fails to meet primary endpoint, but experts agree results are...
Data from the randomised controlled ATTRACT trial revealed that the addition of catheter-based intervention to standard-of-care anticoagulation failed to significantly decrease the occurrence of...
ATTRACT trial results to be presented at SIR 2017 meeting
Suresh Vedantham, professor of Radiology and Surgery, Mallinckrodt Institute of Radiology, Washington University School of Medicine in St Louis, USA, is scheduled to present the...
Majority of patients treated with embolization for symptomatic fibroids can avoid...
Ten-year outcomes from the randomised controlled EMMY trial were presented at CIRSE 2016 (10–14 September, Barcelona, Spain) by Jim Reekers, Academic Medical Center, Amsterdam,...
